Diagnosis (3) Patients (3) Impact (3) Evaluation (3) Diagnosis (3) Brain (3) Tax assessment (3) Patients (3) cerveau (3) âge (2) survie (2) Methods (2) Epidermal growth factor (2) Survival (2) Metastasis (2) Age (2) Adenocarcinoma (2) Addition (2) Methods (2) Age (2) tumeur (1) tissu (corporel) (1) temps (durée) (1) risque (1) qualité de vie (1) perte (1) in situ (1) hybridation (1) histoire (1) santé (1)